Simon Leboube

Glad to be back at #aha2022 in Chicago with my colleagues @sleboube @PaillardMel @GomezLudovik @CHUdeLyon @HCL_research @LaboratoryIris

🙏 Dans le cadre des Journées de l’Avenir organisées dans tous les clubs de LNB, Gaëtan Muller, Alain Béral, Président de la @LNBofficiel et Marion Lelouvier, Présidente de la @FondationAvenir, remettent le chèque à Mélanie Paillard, chercheuse à l’hôpital Lyon Sud ! #LDLCASVEL

Félicitations au Professeur Marco Vola du GHE cardiologie des Hospices Civils de Lyon pour l’obtention de son projets RHU (Recherche Hospitalo-Universitaire en santé) : « ICELAND » @HCL_research @CarMeN_lab_Lyon @InsermAuRA @CHUdeLyon

les Journées de l'Avenir ! L'équipe Lyonnaise @LaboratoryIris a été sélectionnée pour ses recherches dans le domaine cardiovasculaire par la LNB @LNBofficiel et à la @FondationAvenir pour faire avancer la recherche médicale journeesdelavenir.fr merci de diffuser

From @jaccjournals jacc.org/doi/10.1016/j.… Check our latest article! @BochatonThomas @mewton_nathan @CHUdeLyon @alexPaccalet

Our latest article: Prognosis value of serum soluble ST2 level in acute ischemic stroke and STEMI patients in the era of mechanical rep… pubmed.ncbi.nlm.nih.gov/34694426/ @alexPaccalet @crola_da @mewton_nathan @sleboube

After his excellent thesis defense, Alexandre Paccalet is now in Nahrendorf laboratory (Harvard University, Boston) for his post-doctoral fellowship, Good luck in your future research Alex! @LaboratoryIris @CarMeN_lab_Lyon @MatthiasNahrend @alexPaccalet @HCL_research @Inserm

Serum soluble Tumor Necrosis Factor Receptor (sTNFR) 1 and 2 are early prognosis markers after STEMI frontiersin.org/article/10.338… @alexPaccalet @crola_da @sleboube @mewton_nathan @CHUdeLyon @Inserm @LaboratoryIris

Transcatheter mitral valve repair to treat postmyocardial infarction papillary muscle rupture Hayek A, Grinberg D, Derimay F, Bochaton T - J Cardiovasc Echography jcecho.org/article.asp?is… @BochatonThomas @dnlgrinberg @CHUdeLyon

Acute pulmonary embolism and thrombus entrapped in the patent foramen ovale in a patient with COVID-19 Hayek A, Flagiello M, Aubry M, Bochaton T - J Cardiovasc Echography jcecho.org/article.asp?is…

📣Great news for our PhD student @alexPaccalet, who recently got supported by @Servier Institute for his post-doctoral project in @Harvard! 📝 @CarMeN_lab_Lyon @HCL_research @InsermAuRA

Soluble C-Met is a biomarker of clinical outcomes after STEMI From @jaccjournals jacc.org/doi/10.1016/j.… @BochatonThomas @alexPaccalet @crola_da @mewton_nathan @CHUdeLyon @LaboratoryIris @fedecardio @AngoulvantD

Our Phd student have something to say about myocardial ischemia-reperfusion injury and diabetes!! !! 🫀💊 frontiersin.org/article/10.338… @MayaDia1 @alexPaccalet @crola_da @BochatonThomas @CarMeN_lab_Lyon @FrontiersIn @InsermAuRA @HCL_research #cardiotwitter

Our last article: Kinetics and prognostic value of soluble VCAM‐1 in ST‐segment elevation myocardial infarction patients onlinelibrary.wiley.com/doi/10.1002/ii… @AhmadHayek0 @mewton_nathan @crola_da @alexPaccalet @FabriceIvanes @CHUdeLyon @CarMeN_lab_Lyon @Inserm

Hey #cardiotwitter 📣 RIFIFI study is out 📣 Myocardial hemorrhage present a strongest relationship with inflammatory biomarkers release compare to persistant MVO or edema in STEMI patients 🫀🔥 @BochatonThomas @mewton_nathan @CarMeN_lab_Lyon @CHUdeLyon

Hsp-70 as a biomarker of Clinical outcomes after STEMI. @JACCJournals @BochatonThomas @ovizem @CHUdeLyon @mewton_nathan onlinejacc.org/content/75/1/1….